Related Experiment Video
Updated: Dec 29, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Voxelotor: First Approval
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. dru@adis.com.
Voxelotor (Oxbryta™) is a novel treatment for sickle cell disease, approved in the USA. This hemoglobin S polymerization inhibitor offers a new disease-modifying option for patients.
Area of Science:
- Hematology
- Pharmacology
Background:
- Sickle cell disease (SCD) is a genetic blood disorder characterized by abnormal hemoglobin.
- Current treatments for SCD focus on managing symptoms and complications.
Purpose of the Study:
- To summarize the development milestones of voxelotor.
- To highlight its first global approval as a disease-modifying agent for SCD.
Main Methods:
- Review of clinical development of voxelotor.
- Analysis of regulatory milestones and trial data.
Main Results:
- Voxelotor (Oxbryta™) received US FDA accelerated approval in November 2019.
- Approval was based on Phase III HOPE trial results for SCD treatment in patients aged ≥12 years.
Conclusions:
- Voxelotor represents a significant advancement in SCD therapy.
- The drug has received Orphan Drug designation and Priority Medicine status in Europe.
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Preclinical Development: Overview
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Targeted Cancer Therapies
There are several types of targeted therapies against...

